Menu
Montecito
PacPremier
Loading...
You are here:  Home  >  'Atara Biotherapeutics'  -  Page 3
Latest

Atara Biotherapeutics gets OK to study multiple sclerosis treatment

By   /  Friday, January 12th, 2018  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Atara Biotherapeutics gets OK to study multiple sclerosis treatment

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Atara Biotherapeutics stock falls on details of secondary stock offering

By   /  Thursday, January 4th, 2018  /  Central Coast Health Watch, Earnings, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Atara Biotherapeutics stock falls on details of secondary stock offering

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Conejo Spectrum lands Atara Biotherapeutics

By   /  Friday, March 31st, 2017  /  Columns, Latest news, Real Estate  /  Comments Off on Conejo Spectrum lands Atara Biotherapeutics

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Atara Biotherapeutics angles for $92M, but jobs are scarce

By   /  Friday, August 29th, 2014  /  Central Coast Health Watch, East Ventura County, Technology, Top Stories, Tri-County Economy  /  Comments Off on Atara Biotherapeutics angles for $92M, but jobs are scarce

Atara is among a new breed of “virtual” biotech startups. Such firms operate with barebones staff and outsource research and manufacturing operations to contract organizations. They are becoming increasingly common as investors seek to mitigate the huge risks of bringing drugs to market, a process that can cost as much as $1.8 billion, according to industry estimates.

Read More →
Latest

Round 2: Atara raises $13.5M as T.O. biotech boom takes hold

By   /  Friday, January 17th, 2014  /  Technology, Top Stories  /  Comments Off on Round 2: Atara raises $13.5M as T.O. biotech boom takes hold

Thousand Oaks-based Atara Biotherapeutics has brought on more investors to its second financing round, bringing the total raised to $52 million.

Read More →
Latest

Atara raises $38.5M for dialysis, cancer drugs

By   /  Friday, December 20th, 2013  /  East Ventura County, Technology, Top Stories, Tri-County Economy  /  Comments Off on Atara raises $38.5M for dialysis, cancer drugs

Atara Biotherapeutics, a Thousand Oaks firm that emerged last year with major Silicon Valley backers and licenses to develop six Amgen assets, has raised $38.5 million to pursue treatments for dialysis complications and ovarian cancer.

Read More →
Latest

Kleiner Perkins startup could spell new era for Amgen

By   /  Friday, November 2nd, 2012  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Kleiner Perkins startup could spell new era for Amgen

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →